News | November 15, 2022
IOL Chemicals and Pharmaceuticals Q2FY23 net profit drops to Rs 15.6 Cr
The company registered with REACH Certificate for Ethyl Acetate with a tonnage band of more than 1000 TPA
The company registered with REACH Certificate for Ethyl Acetate with a tonnage band of more than 1000 TPA
Pantoprazole Sodium Sesquihydrate are proton pump inhibitors used in drugs to suppress the gastric acid secretion
The company is now introducing the product into the India pharmaceutical market.
Therapeutic use of the product is for short term symptomatic relief of colds, chills and influenza including chesty coughs
Omicron patients below 60 with no comorbidities can start treatment with paracetamol
A long waiting period for critical equipment and a 50% hike in the cost of APIs imported from China are among the immediate challenges
India is dependent upon China and other countries for a lot of Key Starting Materials (KSM) for their bulk drug needs.
NPPA has capped the trade margin for Oxygen Concentrators at 70% on Price to Distributor (PTD) level
The company has an outlay of Rs 120-140 crore as R & D expense for FY 22
The company has decided to transfer our rights in relation to the lodex and Ostocalcium brands to GlaxoSmithKline Asia Private Limited
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
